Ignite Creation Date:
2025-12-25 @ 1:05 AM
Ignite Modification Date:
2026-02-25 @ 9:30 PM
Study NCT ID:
NCT03045393
Status:
WITHDRAWN
Last Update Posted:
2018-07-05
First Post:
2017-02-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Mirvetuximab Soravtansine (IMG853) in Folate Receptor Alpha-expressing TNBC
Sponsor:
Duke University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Pro00074621
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NETWORK | View |